학술논문

Favorable Modulation of Chimeric Antigen Receptor T Cells Safety and Efficacy By the Non-Covalent BTK Inhibitor Vecabrutinib
Document Type
Article
Source
Transplantation and Cellular Therapy; March 2022, Vol. 28 Issue: 3, Number 3 Supplement 1 pS167-S167, 1p
Subject
Language
ISSN
26666375; 26666367